2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
7
Prostatic Neoplasms
5
Brain Neoplasms
5
Carcinoma, Non-Small-Cell Lung
3
Radiation Injuries
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hemangioma
2
Breast Neoplasms
2
Urogenital Neoplasms
1
Scleroderma, Localized
1
Respiratory Distress Syndrome
1
Radiation Pneumonitis
1
Popliteal Cyst
1
Polycystic Ovary Syndrome
1
Pneumonia, Viral
1
Pneumonia
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Optic Neuritis
1
Neurodermatitis
1
Neoplastic Cells, Circulating
1
Neoplasms, Fibrous Tissue
1
Neoplasms, Connective and Soft Tissue
1
Neoplasms, Connective Tissue
1
Neoplasms by Histologic Type
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Interventions
Blood Specimen Collection
29
Reverse Transcriptase Polymerase Chain Reaction
7
Flow Cytometry
7
Surgical Procedures, Operative
4
Liquid Biopsy
4
cabazitaxel
3
Trastuzumab
3
Propofol
3
Carboplatin
3
Bevacizumab
3
Standard of Care
2
Spinal Puncture
2
Sevoflurane
2
Positron Emission Tomography Computed Tomography
2
Pirinitramide
2
Neoadjuvant Therapy
2
Morphine
2
Laparoscopy
2
Hematologic Tests
2
Gemcitabine
2
Folfox protocol
2
Epirubicin
2
Drug Therapy
2
Docetaxel
2
Cyclophosphamide
2
Cisplatin
2
Cetuximab
2
Capecitabine
2
Aspirin
2
Anesthesia, General
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplastic Cells, Circulating
×
Adrenal Cortex Hormones
×
Clear all
NCT03050866
2021-08-20
CABA-V7
Erasmus Medical Center
Phase 2
Unknown
140 enrolled